Sickle Cell Drug Development Gains Momentum Across Disease Spectrum
Transplants An Alternative To Genetic Medicines For Some
The recent ASH meeting began with US FDA approvals of the first genetic medicines for sickle cell disease, but doctors and biopharma companies still see a need for new oral therapies and other options.
